The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Actinogen Medical (ASX:ACW) is developing a promising oral treatment for Alzheimer’s and depression and is accelerating clinical trials with new capital.

CEO Steven Gourlay, joins The Market Online to discuss the company’s development.

Join the discussion: See what HotCopper users are saying about Actinogen Medical Ltd and be part of the conversations that move the markets.

ACW by the numbers
More From The Market Online
The Market Online Video

ASX Market Close: Bourse closes flat after Min Res AGM | November 21, 2024

Besieged Mineral Resources (ASX:MIN) Managing Director Chris Ellison told its AGM he deeply regrets his dodgy…
Man holding health IT icon

Alcidion inks deal with Vic health provider Peninsula for use of Miya Precision tech

Alcidion Group Ltd has signed a contract worth $3.7M to enable use of its Miya Precision…
Two Symal Group workers.

Quiet day one for Symal Group but slow ASX start no real surprise

Civil construction company Symal Group (ASX:SYL) had a relatively quiet first day after
Confused reader

MinRes’s Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Who the MinRes Board has decided to move on faster may or may not be amusing,…